Silva Paul M — SEC insider filings

SEC reporting owner CIK 1446372. 17 insider filings on record with FilingPulse; latest filed 2026-10-22.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-08-10 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)SVP & Chief Accounting Officer7—17 legs · 10,733 sh · $2,336,39011
Rapport Therapeutics, Inc. (RAPP)Director41 leg · 3,680 sh · $99,636—3
Nurix Therapeutics, Inc. (NRIX)Director6——6

Insider filings — Silva Paul M

FiledFormIssuerReported transactionsSource
2026-10-224Rapport Therapeutics, Inc. (RAPP)Purchase (P): 3,680 @ $27.07EDGAR
2026-06-104Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 15,200 (derivative) @ $0EDGAR
2026-05-154Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 31,250 (derivative) @ $0EDGAR
2025-06-184Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 10,925 (derivative) @ $0EDGAR
2025-05-194Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-11-074Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 29,756 (derivative) @ $0EDGAR
2024-05-204Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-05-044Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-05-064Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2021-10-044Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2021-03-024VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,218 @ $212.42 · Sale (S): 1,026 @ $210.13 · Sale (S): 610 @ $211.45 · Sale (S): 915 @ $212.51 · Sale (S): 231 @ $213.12EDGAR
2021-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 864 @ $217.57 · Sale (S): 244 @ $211.80 · Sale (S): 452 @ $213.12 · Sale (S): 258 @ $214.32 · Sale (S): 126 @ $216.25EDGAR
2021-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,740 @ $211.75 · Sale (S): 584 @ $210.05 · Sale (S): 2,343 @ $211.82 · Sale (S): 1,368 @ $212.62EDGAR
2021-02-164VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 1,288 @ $210.45 · Sale (S): 210 @ $211.32EDGAR
2021-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 651 @ $214.16EDGAR
2021-02-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 4,220 @ $0 · Grant/award (A): 3,226 @ $0 · Grant/award (A): 3,634 @ $0EDGAR
2020-08-104VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 466 @ $187.53 · Option exercise (M): 612 @ $155.57 · Sale (S): 420 @ $270.12 · Sale (S): 211 @ $270.92 · Sale (S): 373 @ $272.15 · Sale (S): 74 @ $272.87 · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1446372 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs